Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $818.69 billion, total revenue of $172.88 billion and a weighted average PE ratio of 45.58.
Market Cap
818.69B
Revenue
172.88B
Profits
17.96B
PE Ratio
45.58
Profit Margin
10.39%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 219.63B | 2.41% | 2,206,675 | 46.34B |
| 2 | DHR | Danaher Corporation | 143.94B | 2.39% | 3,323,841 | 25.11B |
| 3 | NTRA | Natera, Inc. | 46.43B | 21.37% | 3,386,662 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 46.22B | -0.56% | 589,392 | 4.55B |
| 5 | A | Agilent Technologies, Inc. | 41.23B | 3.28% | 1,525,215 | 7.23B |
| 6 | WAT | Waters Corporation | 39.95B | 1.79% | 891,257 | 4.64B |
| 7 | IQV | IQVIA Holdings Inc. | 39.29B | 2.70% | 1,086,329 | 16.98B |
| 8 | MTD | Mettler-Toledo International Inc. | 28.64B | 0.58% | 123,700 | 4.13B |
| 9 | ILMN | Illumina, Inc. | 28.38B | -2.97% | 1,819,050 | 4.49B |
| 10 | DGX | Quest Diagnostics Incorporated | 26.31B | -0.06% | 576,519 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.88B | 0.83% | 429,350 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 22.61B | 6.92% | 2,193,758 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.49B | 0.97% | 136,482 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 12.79B | 0.37% | 1,050,532 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 12.77B | 0.75% | 612,507 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.69B | 2.07% | 388,372 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.75B | 1.37% | 3,796,107 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 7.25B | 6.04% | 1,561,406 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 5.69B | 6.20% | 1,470,214 | 2.14B |
| 20 | SHC | Sotera Health Company | 5.38B | -0.26% | 3,374,632 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.41B | 1.90% | 1,530,328 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.98B | 5.64% | 2,494,979 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.80B | 2.32% | 787,622 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 3.10B | 9.59% | 1,643,780 | 165.26M |
| 25 | CDNA | CareDx, Inc. | 2.42B | 4.20% | 965,421 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.30B | 10.76% | 1,068,585 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.13B | 6.49% | 1,346,624 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.51B | 8.67% | 3,211,584 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.26B | 1.56% | 548,580 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 1.02B | 3.79% | 2,699,962 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 978.50M | 5.12% | 241,774 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 526.64M | 3.18% | 228,360 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 311.82M | 2.52% | 1,440,869 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 243.36M | 6.33% | 80,693 | 102.94M |
| 35 | XGN | Exagen Inc. | 166.43M | 4.25% | 431,787 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 155.96M | 0.63% | 41,981 | 1.95M |
| 37 | BNR | Burning Rock Biotech Limited | 92.91M | -0.79% | 1,807 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 42.84M | 2.13% | 62,781 | 25.83M |
| 39 | QUCY | Quantum Cyber N.V. | 32.78M | 4.35% | 777,398 | 537.08K |
| 40 | MDXH | MDxHealth SA | 23.68M | 5.23% | 509,638 | 110.97M |
| 41 | MBAI | Check-Cap Ltd. | 10.90M | -1.40% | 70,851 | - |
| 42 | ADVB | Advanced Biomed Inc. | 10.52M | -14.38% | 65,209 | - |
| 43 | XWEL | XWELL, Inc. | 8.66M | -5.09% | 36,971 | 28.83M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.84M | 0.55% | 3,888 | - |
| 45 | ISPC | iSpecimen Inc. | 3.19M | 0.91% | 61,084 | 1.03M |
| 46 | BIAF | bioAffinity Technologies, Inc. | 2.31M | -3.72% | 528,046 | 5.90M |